Safe and pragmatic use of sodium-glucose co-transporter 2 inhibitors in type 2 diabetes mellitus: South Asian Federation of Endocrine Societies consensus statement.

Add to Collection

2017 Jan-Feb Clinical Guidelines and Recommendations S Kalra, S Ghosh, AH Aamir, MT Ahmed… - Indian journal of …, 2017 - ncbi.nlm.nih.gov 121

Full Author : ['Kalra, Sanjay', 'Ghosh, Sujoy', 'Aamir, A H', 'Ahmed, Md Tofail', 'Amin, Mohammod Feroz', 'Bajaj, Sarita', 'Baruah, Manash P', 'Bulugahapitiya, Uditha', 'Das, A K', 'Giri, Mimi', 'Gunatilake, Sonali', 'Mahar, Saeed A', 'Pathan, Md Faruque', 'Qureshi, Nazmul Kabir', 'Raza, S Abbas', 'Sahay, Rakesh', 'Shakya, Santosh', 'Shreshta, Dina', 'Somasundaram, Noel', 'Sumanatilleke, Manilka', 'Unnikrishnan, A G', 'Wijesinghe, Achini Madushani']
Journal Title : Indian journal of endocrinology and metabolism
Chapter : Section4
Journal Year : 2017
Cited by : 36

Diabetes prevalence shows a continuous increasing trend in South Asia. Although well-established treatment modalities exist for type 2 diabetes mellitus (T2DM) management, they are limited by their side effect profile. Sodium-glucose co-transporter 2 inhi..... Read More

Keywords : ['type diabete mellitus south asian federation', 'endocrine societies consensus statement', 'sodiumglucose cotransporter inhibitor', 'pragmatic use', 'safe']
PubMed Link : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240067/
Google Scholar Link : https://scholar.google.com/scholar?cites=9700103229410408503&as_sdt=2005&sciodt=0,5&hl=en&num=20

Have a Question?

Safe and pragmatic use of sodium-glucose co-transporter 2 inhibitors in type 2 diabetes mellitus: South Asian Federation of Endocrine Societies consensus statement.